Core One Labs Stock Net Income

As of the 12th of February 2026, Core One shows the Mean Deviation of 3.22, risk adjusted performance of (0.09), and Standard Deviation of 12.8. Core One Labs technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Core One Labs mean deviation, total risk alpha, kurtosis, as well as the relationship between the standard deviation and maximum drawdown to decide if Core One Labs is priced correctly, providing market reflects its regular price of 0.0 per share.
Core One's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Core One's valuation are provided below:
Core One Labs does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
It's important to distinguish between Core One's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Core One should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Core One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Core One 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Core One's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Core One.
0.00
11/14/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/12/2026
0.00
If you would invest  0.00  in Core One on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Core One Labs or generate 0.0% return on investment in Core One over 90 days. Core One is related to or competes with Sigyn Therapeutics, and Healthlynked Corp. Core One Labs Inc. operates as a biotechnology research and technology life sciences company More

Core One Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Core One's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Core One Labs upside and downside potential and time the market with a certain degree of confidence.

Core One Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Core One's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Core One's standard deviation. In reality, there are many statistical measures that can use Core One historical prices to predict the future Core One's volatility.
Hype
Prediction
LowEstimatedHigh
0.000.0012.80
Details
Intrinsic
Valuation
LowRealHigh
0.000.0012.80
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Core One. Your research has to be compared to or analyzed against Core One's peers to derive any actionable benefits. When done correctly, Core One's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Core One Labs.

Core One February 12, 2026 Technical Indicators

Core One Labs Backtested Returns

Core One Labs secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. Core One Labs exposes thirteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Core One's Mean Deviation of 3.22, risk adjusted performance of (0.09), and Standard Deviation of 12.8 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.15, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Core One are expected to decrease at a much lower rate. During the bear market, Core One is likely to outperform the market. At this point, Core One Labs has a negative expected return of -1.64%. Please make sure to confirm Core One's mean deviation, total risk alpha, kurtosis, as well as the relationship between the standard deviation and maximum drawdown , to decide if Core One Labs performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.00  

No correlation between past and present

Core One Labs has no correlation between past and present. Overlapping area represents the amount of predictability between Core One time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Core One Labs price movement. The serial correlation of 0.0 indicates that just 0.0% of current Core One price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test-0.24
Residual Average0.0
Price Variance0.0
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Core One Labs reported net income of (37.05 Million). This is 110.86% lower than that of the Healthcare sector and 152.9% lower than that of the Biotechnology industry. The net income for all United States stocks is 106.49% higher than that of the company.

Core Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core One's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Core One could also be used in its relative valuation, which is a method of valuing Core One by comparing valuation metrics of similar companies.
Core One is currently under evaluation in net income category among its peers.

Core Fundamentals

About Core One Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Core One Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core One using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core One Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Core Pink Sheet

Core One financial ratios help investors to determine whether Core Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Core with respect to the benefits of owning Core One security.